Po-Chen Chu - Search Results

Year	Number of Results
2004	1
2006	1
2009	1
2011	2
2012	5
2013	2
2016	6
2017	3
2018	4
2019	4
2020	4
2021	2
2022	5
2023	4
2024	1

1

Chu PC, Kulp SK, Chen CS. Chu PC, et al. Carcinogenesis. 2017 Jan;38(1):105-106. doi: 10.1093/carcin/bgw117. Epub 2016 Nov 21. Carcinogenesis. 2017. PMID: 28064180 Free PMC article. Retracted. No abstract available.

2

A PKM2 inhibitor induces apoptosis and autophagy through JAK2 in human oral squamous cell carcinoma cells.

Weng JR, Gopula B, Chu PC, Hu JL, Feng CH. Weng JR, et al. Among authors: chu pc. Chem Biol Interact. 2023 Aug 1;380:110538. doi: 10.1016/j.cbi.2023.110538. Epub 2023 May 8. Chem Biol Interact. 2023. PMID: 37164279

3

Novel HIF-1α inhibitor CDMP-TQZ for cancer therapy.

Chu PC, Wu YC, Chen CY, Hung YS, Chang CS. Chu PC, et al. Future Med Chem. 2021 Jun;13(12):1057-1072. doi: 10.4155/fmc-2020-0307. Epub 2021 Apr 26. Future Med Chem. 2021. PMID: 33896195

4

Novel 4-aminoquinoline analogs targeting the HIF-1α signaling pathway.

Wu YC, Lu MT, Chu PC, Chang CS. Wu YC, et al. Among authors: chu pc. Future Med Chem. 2023 Sep;15(17):1569-1582. doi: 10.4155/fmc-2023-0169. Epub 2023 Sep 20. Future Med Chem. 2023. PMID: 37728024

5

Therapeutic Opportunities of Targeting Histone Deacetylase Isoforms to Eradicate Cancer Stem Cells.

Lin PC, Hsieh HY, Chu PC, Chen CS. Lin PC, et al. Among authors: chu pc. Int J Mol Sci. 2018 Jul 2;19(7):1939. doi: 10.3390/ijms19071939. Int J Mol Sci. 2018. PMID: 30004423 Free PMC article. Review.

6

Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors.

Hsieh IS, Gopula B, Chou CC, Wu HY, Chang GD, Wu WJ, Chang CS, Chu PC, Chen CS. Hsieh IS, et al. Among authors: chu pc. J Med Chem. 2019 Sep 26;62(18):8497-8510. doi: 10.1021/acs.jmedchem.9b00763. Epub 2019 Sep 16. J Med Chem. 2019. PMID: 31465224

7

Synthesis and evaluation of biarylquinoline derivatives as novel HIF-1α inhibitors.

Wu YC, Lu MT, Lin TH, Chu PC, Chang CS. Wu YC, et al. Among authors: chu pc. Bioorg Chem. 2022 Apr;121:105681. doi: 10.1016/j.bioorg.2022.105681. Epub 2022 Feb 12. Bioorg Chem. 2022. PMID: 35176558

8

Synthesis and Structure-Activity Relationship of Salvinal Derivatives as Potent Microtubule Inhibitors.

Chang CI, Hsieh CC, Wein YS, Kuo CC, Chang CY, Lung J, Cherng JY, Chu PC, Chang JY, Kuo YH. Chang CI, et al. Among authors: chu pc. Int J Mol Sci. 2023 Mar 28;24(7):6386. doi: 10.3390/ijms24076386. Int J Mol Sci. 2023. PMID: 37047358 Free PMC article.

9

A non-invasive mouse model that recapitulates disuse-induced muscle atrophy in immobilized patients.

Wu KC, Lin HW, Chu PC, Li CI, Kao HH, Lin CH, Cheng YJ. Wu KC, et al. Among authors: chu pc. Sci Rep. 2023 Dec 14;13(1):22201. doi: 10.1038/s41598-023-49732-8. Sci Rep. 2023. PMID: 38097709 Free PMC article.

10

Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.

Wu KC, Chu PC, Cheng YJ, Li CI, Tian J, Wu HY, Wu SH, Lai YC, Kao HH, Hsu AL, Lin HW, Lin CH. Wu KC, et al. Among authors: chu pc. J Cachexia Sarcopenia Muscle. 2022 Aug;13(4):2073-2087. doi: 10.1002/jcsm.13028. Epub 2022 Jun 19. J Cachexia Sarcopenia Muscle. 2022. PMID: 35718751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year